SINGLE-CELL DNA ANALYSIS OF MUTATIONAL HETEROGENEITY IN ACUTE MYELOID LEUKEMIA TUMORS WITH HIGH-THROUGHPUT DROPLET MICROFLUIDICS
EHA Learning Center, Dennis Eastburn, 214633
CANDIDATE FDA-APPROVED DRUGS THAT MAY MIMIC HOXA CLUSTER DELETION IN MLL-AF9 LEUKEMIA.
EHA Learning Center, Laura Kettyle, 214634
INFLAMED BM-MSCS HIGHLY ATTRACT TEL-AML1+ PRE-LEUKEMIC CELLS AND PROVIDE A SUSTAINING NICHE FOR THEIR EMERGENCE
EHA Learning Center, Linda Beneforti, 215233
TRANSLATOME ANALYSIS REVEALS ALTERED SERINE METABOLISM IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Learning Center, Kim Kampen, 215234
GENETIC ALTERATIONS OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN TAIWAN: A COMPARISON BETWEEN PEDIATRIC AND ADULT COHORTS
EHA Learning Center, Ying-Jung Huang, 215250
FIRST RESULTS OF NEW GIMEMA TRIAL LAL1913 FOR ADULT PATIENTS WITH PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH- ALL)
EHA Learning Center, Renato Bassan, 215251
PLASMA PROTEOME IN PATIENTS WITH LEUKEMIA AND LYMPHOMA REVEALS MAJOR DIFFERENCES RELATED TO HEMOSTASIS, INFLAMMATION AND STROMA
EHA Learning Center, Anna Eriksson, 215267
IDENTIFICATION OF CALM/AF10 (PICALM/MLLT10) COOPERATING MUTATIONS IN A ZEBRAFISH LEUKAEMIA MODEL
EHA Learning Center, Omid Delfi, 215268
PHOSPHO-PROFILING LINKING AML-BIOLOGY AND RESPONSE PREDICTION IN PEDIATRIC MYELOID LEUKEMIA
EHA Learning Center, Michaela Prchal-Murphy, 215283
TOWARDS IMPROVING OF SURVIVAL IN AML BY REPURPOSING EXISTING DRUGS AS NOVEL SAMHD1 INHIBITORS
EHA Learning Center, Nikolaos Tsesmetzis, 215284
THE DIFFERENTIAL EXPRESSION OF DNMT3A SPLICE VARIANTS AND THEIR PROGNOSTIC RELEVANCE IN ACUTE MYELOID LEUKEMIA
EHA Learning Center, Stefanie Beinicke, 215300
P53(D281G) MUTATION CAUSES CYTARABINE RESISTANCE VIA PROMOTING WARBURG EFFECT IN ACUTE MYELOID LEUKEMIA CELLS
EHA Learning Center, Kit Man Ng, 215301
MRD STATUS AT TRANSPLANTATION IN SECOND OR THIRD CR IS THE STRONGEST FACTOR AFFECTING THE PROBABILITY OF RELAPSE IN AML PATIENTS
EHA Learning Center, Fabio Guolo, 215316
THE CXCR4 INHIBITOR BL-8040 IN COMBINATION WITH CYTARABINE RESULTS IN A SIGNIFICANTLY EXTENDED OVERALL SURVIVAL OF RELAPSED/REFRACTORY AML PATIENTS
EHA Learning Center, Gautam Borthakur, 215317
BLAST TRANSFORMATION IN MYELODYSPLASTIC AND MYELOPROLIFERATIVE NEOPLASMS - SIMILARITIES AND DIFFERENCES - A REVIEW OF 100 CASES
EHA Learning Center, Milan Jagurinoski, 215332
QUALITY OF LIFE IN ACUTE LEUKEMIA PATIENTS WITH COMORBID ISCHEMIC HEART DISEASE
EHA Learning Center, Tetiana Lymanets, 215333
A NOVEL IMMUNOHISTOCHEMICAL PROGNOSTIC SCORE BASED ON MYC, BCL2 AND BCL6 EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): RETROSPECTIVE ANALYSIS OF DE NOVO DLBCL TREATED WITH RITUXIMAB-CHOP
EHA Learning Center, Mattia Novo, 215348
ASSESSMENT OF BONE MARROW INFILTRATION AND MINIMAL RESIDUAL DISEASE BY MULTIDIMENSIONAL FLOW CYTOMETRY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
EHA Learning Center, M Baile, 215349
BEVACIZUMAB SIGNIFICANTLY IMPROVES SEVERE EPISTAXIS IN HEREDITARY HEMORRHAGIC TELANGIECTASIA
EHA Learning Center, Silva ZUPANCIC SALEK, 215364
AN AUDIT OF THE USE OF PROTHROMBIN COMPLEX CONCENTRATION
EHA Learning Center, Samantha Bonney, 215365
RESULTS OF HEMATOPOIETIC STEM CELLS TRANSPLANTATION IN CONGENITAL BONE MARROW FAILURE SYNDROMES: SINGLE CENTER EXPERIENCE WITH FOCUS ON TCR ΑΒ+/CD19+ DEPLETION
EHA Learning Center, Zhanna Shekhovtsova, 215380
REACTIVATION OF HEPATITIS B VIRUS INFECTION IN APLASTIC ANEMIA PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY
EHA Learning Center, Guangsheng He, 215381
NEXT-GENERATION SEQUENCING AND CRISPR/CAS9 APPLICATION TO ELUCIDATE THE IMPLICATIONS OF TP53 MUTATIONS IN DEL(13Q) CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Learning Center, Miguel Quijada Alamo, 215396
ENCYCLOPEDIA OF CLL SUBSETS: AN ONLINE KNOWLEDGEBASE FOR SUBSETS OF CLL CASES WITH STEREOTYPED B CELL RECEPTORS
EHA Learning Center, Tomas Reigl, 215397
ANALYSIS OF LOCUS-SPECIFIC LINE-1 AND ALU ELEMENT DNA METHYLATION REVEALS NOVEL EARLY EPIGENETIC CHANGES IN CHRONIC LYMPHOCYTIC LEUKAEMIA
EHA Learning Center, Timothy Barrow, 215398
A PROGNOSTIC TOOL FOR THE IDENTIFICATION OF EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS AT IMMINENT RISK OF PROGRESSION
EHA Learning Center, Lodovico Terzi di Bergamo, 215412
SURVIVAL CONTINUES TO INCREASE IN CHRONIC LYMPHOCYTIC LEUKEMIA: A POPULATION-BASED ANALYSIS AMONG 19,131 PATIENTS DIAGNOSED IN THE NETHERLANDS BETWEEN 1989 AND 2015
EHA Learning Center, Lina van der Straten, 215413
PROGNOSTICATION AND FIRST-LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: A CONTEMPORARY, NATIONWIDE, POPULATION-BASED ANALYSIS AMONG 1,677 PATIENTS DIAGNOSED IN THE NETHERLANDS
EHA Learning Center, Lina van der Straten, 215414
CLONAL SELECTION DETERMINES RESULTANT DOMINANCE OF TYROSINE KINASE INHIBITOR-RESISTANT CELLS IN CHRONIC MYELOID LEUKAEMIA
EHA Learning Center, Benjamin Leow, 215428
WT1 ANALYSIS IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS
EHA Learning Center, Sabrina COLUZZI, 215429
DIGITAL DROPLET PCR MAY BETTER IDENTIFY CANDIDATES FOR TREATMENT DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA REGARDLESS OF MEDIAN TREATMENT DURATION
EHA Learning Center, Gioia colafigli, 215430
THE TARGET UK STUDY: AN EVALUATION OF TYROSINE KINASE INHIBITOR RESPONSE MONITORING PATTERNS AND REAL-WORLD MOLECULAR RESPONSE RATES IN UK PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
EHA Learning Center, Adam Mead, 215444
THE OCCURRENCE AND SURVIVAL OF COLD AGGLUTININ DISEASE IN DENMARK
EHA Learning Center, Sigbjørn Berentsen, 215445
DENSITY, HETEROGENEITY AND DEFORMABILITY OF RED CELLS AS MARKERS OF CLINICAL SEVERITY IN HEREDITARY SPHEROCYTOSIS
EHA Learning Center, Richard van Wijk, 215446
IMMUNOGENICITY OF TISAGENLECLEUCEL IN RELAPSED/ REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) AND DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS
EHA Learning Center, Theodore Laetsch, 215461
CONSIDERATIONS FOR TISAGENLECLEUCEL DOSING RATIONALE
EHA Learning Center, Rakesh Awasthi, 215462
MTL-CEBPA, A SMALL ACTIVATING RNA FOR INTRAVENOUS ADMINISTRATION TO ENHANCE C/EBPΑ EXPRESSION IN PATIENTS WITH LIVER CANCER SHOWS POTENTIAL USE IN NEUTROPENIA
EHA Learning Center, Choon Tan, 215463
ALTERATIONS IN STROMAL PRECURSOR CELLS IN THE BONE MARROW OF PATIENTS WITH LEUKEMIA IN THE ONSET OF THE DISEASE AND AFTER TREATMENT
EHA Learning Center, Nataliya Petinati, 215477
LYMPHOPENIA AND RISK OF INFECTIONS AND INFECTION-RELATED DEATH IN DENMARK, 2003-2013: A PROSPECTIVE COHORT STUDY OF 98,344 INDIVIDUALS FROM THE GENERAL POPULATION
EHA Learning Center, Marie Warny, 215478
HEMATOPOIETIC EFFECTS OF A COMPOUND: SXN AGAINST MYELOSUPPRESSION
EHA Learning Center, Fuling Zhou, 215479
IMPROVED DEPTH OF RESPONSE WITH INCREASED FOLLOW-UP FOR PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH BRUTON’S TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB
EHA Learning Center, Judith Trotman, 215493
CHARACTERIZATION OF MALT LYMPHOMA WITH T(11;18): LONG-TERM FOLLOW-UP
EHA Learning Center, Kosuke Toyoda, 215494
CLONAL B-CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL-MZ): DESCRIPTION OF MAIN DISEASE FEATURES, CLINICAL COURSE AND OUTCOME IN A SERIES OF 98 CASES.
EHA Learning Center, Christina Kalpadakis, 215495
ANTIBIOTICS CAN SAFELY BE DISCONTINUED IN NEUTROPENIC HEMATOLOGY PATIENTS: A PROSPECTIVE COHORT
EHA Learning Center, Zoe Van de Wyngaert, 215510
RISK OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN THE ERA OF NOVEL THERAPIES: A RETROSPECTIVE SINGLE INSTITUTION EXPERIENCE
EHA Learning Center, Francesco Autore, 215511
THERAPEUTIC ADMINISTRATION OF IGM-ENRICHED IMMUNOGLOBULINS IMPROVES SURVIVAL IN HEMATOLOGICAL CANCER PATIENTS WITH SEVERE NEUTROPENIC SEPSIS
EHA Learning Center, Alessandra Forcina, 215512
TREATMENT WITH FERRIC CARBOXYMALTOSE FOR SEVERE IRON DEFICIENCY ANEMIA IN STABLE NOT ACTIVELY BLEEDING PATIENTS IN THE EMERGENCY DEPARTMENT
EHA Learning Center, Irene Motta, 215527
IRON DEFICIENCY ANAEMIA – ZINC PROTOPORPHYRIN, A SIMPLE, FAST, INEXPENSIVE DIAGNOSTIC METHOD
EHA Learning Center, João Gomes, 215528
STUDY OF A MEDICO-ECONOMIC ADVANTAGE IN USING NEW PARAMETERS OF CBC-DIFF-RETIC IN THE EARLY DETECTION OF IRON DEFICIENCY FOR DIALYSIS PATIENTS**
EHA Learning Center, Elena Sukhacheva, 215529
MULTICENTRIC VALIDATION OF THE “MONOCYTE ASSAY” FOR CHRONIC MYELOMONOCYTIC LEUKEMIA DIAGNOSIS BY FLOW CYTOMETRY
EHA Learning Center, Orianne Wagner-Ballon, 215543
CHARACTERIZATION AND DIFFERENTIAL EFFECTS OF MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
EHA Learning Center, Manja Wobus, 215544
MYELODISPLASTIC SYNDROMES: MECHANISMS INVOLVED IN THE TRANSFORMATION TO ACUTE MYELOID LEUKEMIA (AML)
EHA Learning Center, Francisca Hernández Mohedo, 215545
OUTCOME OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND STABLE DISEASE DURING TREATMENT WITH AZACITIDINE: A REPORT FROM GRUPPO ROMANO MIELODISPLASIE (GROM) AND RETE EMATOLOGICA LOMBARDA (REL).
EHA Learning Center, Luca Maurillo, 215559
PREDICTIVE FACTORS OF OVERALL SURVIVAL AND TREATMENT RESPONSE IN HIGH-RISK OLDER PATIENTS WITH MDS AND CMML UNDER HYPOMETHILATING AGENTS. LATIN-AMERICAN MDS GROUP - GLAM
EHA Learning Center, Marcelo Iastrebner, 215560
IRON SUPPORT ENHANCES ERYTHROPOIETIN EFFECTIVENESS IN REFRACTORY ANEMIA WITH HIGH RETICULOCYTE COUNT, TRANSFERRIN SATURATION BELOW 30% AND HIGH LEVEL OF ERYPTOSIS.
EHA Learning Center, GIULIO GIORDANO, 215561
MITOCHONDRIAL ACTIVITY PLAYS A CRITICAL ROLE IN MULTIPLE MYELOMA RESISTANCE
EHA Learning Center, Alejandra Ortiz, 215576
ELOTUZUMAB PROMOTES SELF-ENGAGEMENT OF SLAMF7 BETWEEN NATURAL KILLER AND MULTIPLE MYELOMA CELLS TO ENHANCE CYTOTOXICITY
EHA Learning Center, Michael D. Robbins, 215577
CARFILZOMIB-INDUCED CARDIOTOXICITY: MOLECULAR MECHANISMS AND THE EMERGING ROLE OF METFORMIN AS A PROPHYLACTIC THERAPY
EHA Learning Center, Evangelos Terpos, 215578
POMALIDOMIDE + LOW-DOSE DEXAMETHASONE + DARATUMUMAB IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA AFTER LENALIDOMIDE-BASED TREATMENT FAILURE
EHA Learning Center, David S. Siegel, 215592
DOUBLET VS TRIPLET LENALIDOMIDE-CONTAINING REGIMENS FOLLOWED BY MAINTENANCE: SUBGROUP ANALYSIS BY FRAILTY STATUS AFTER A MEDIAN FOLLOW-UP OF 5 YEARS (EMN01 PHASE III STUDY)
EHA Learning Center, Sara Bringhen, 215593
POMALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN CASE OF SUBOPTIMAL RESPONSE TO POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA: RESULTS OF THE GMMG-PERSPECTIVE TRIAL
EHA Learning Center, Katja C Weisel, 215594
COMPLETE RESPONSE AND INDUCTION TREATMENT DOES NOT AFFECT SURVIVAL IN MYELOMA PATIENTS RELAPSING WITHIN 18 MONTHS FOLLOWING UP-FRONT HDM-ASCT. A POPULATION-BASED STUDY FROM 1994 TO 2015
EHA Learning Center, Annette Vangsted, 215608
OVERALL SURVIVAL OF PATIENTS POST-TRANSPLANT: STUDY RESULTS FROM TWO PHASE 3 TRIALS ASPIRE AND ENDEAVOR
EHA Learning Center, Hartmut Goldschmidt, 215609
DURABLE PROGRESSION-FREE SURVIVAL BENEFIT IN EARLY RESPONDERS TO ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: ANALYSIS OF 4-YEAR DATA FROM ELOQUENT-2
EHA Learning Center, Christof Scheid, 215610
COMPARISON OF LYMPHOTRACK® MISEQ® ASSAYS AND FLOW CYTOMETRY FOR CLONALITY AND MINIMUM RESIDUAL DISEASE ASSESSMENT IN MULTIPLE MYELOMA
EHA Learning Center, Austin Jacobsen, 215624
QUALITY OF HEMATOLOGIC RESPONSE BUT NOT DEPTH OF NT-PROBNP RESPONSE IMPROVES SURVIVAL OF PATIENTS WITH AL AMYLOIDOSIS WHO ACHIEVE CARDIAC RESPONSE
EHA Learning Center, Paolo Milani, 215625
SUSTAINED MRD NEGATIVITY AT 12 MONTHS POST-ASCT PREDICTS OUTCOMES FOR MYELOMA PATIENTS: A REAL WORLD STUDY.
EHA Learning Center, Michael Austin, 215626
THE SCREENING OF PROTEINS SIGNATURES WITH SIGNALING PATHWAY IN POLYCYTHEMIA VERA AND INHIBITION OF PIM ENHANCES JAK2 INHIBITOR SENSITIVITY
EHA Learning Center, Wuhan Hui, 215640
IMPACT OF MOLECULAR ANALYSIS ON PROGNOSTIC SCORES IN ESSENTIAL THROMBOCYTHEMIA: A SINGLE CENTER PROSPECTIVE COHORT EXPERIENCE
EHA Learning Center, Damien Luque Paz, 215641
THE ROLE OF THE THROMBOPOIETIN RECEPTOR (MPL) IN MYELOPROLIFERATIVE NEOPLASMS
EHA Learning Center, Kira Behrens, 215642
TARGETED TREATMENT WITH DIVERSE TYROSINE KINASE INHIBITORS IN PATIENTS WITH PCM1-JAK2, BCR-JAK2 AND ETV6-ABL1 POSITIVE EOSINOPHILIA-ASSOCIATED MYELOID/LYMPHOID NEOPLASMS
EHA Learning Center, Georgia Metzgeroth, 215656
MANAGEMENT AND OUTCOME OF 25 PREGNANCIES IN WOMEN WITH POLYCYTHAEMIA VERA
EHA Learning Center, Irene Bertozzi, 215657
PEGYLATED INTERFERON ALPHA-2B VERSUS ΑLPHA-2A FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA: EFFICACY AND SAFETY PROFILE.
EHA Learning Center, Novella Pugliese, 215658
SECOND MALIGNANCIES IN HIDROXYUREA AND INTERFERON TREATED PATIENTS
EHA Learning Center, Telma Domingues, 215672
CORRELATIONS BETWEEN GENETIC AND CLINICAL CHARACTERISTICS IN PATIENTS WITH PRIMARY MYELOFIBROSIS
EHA Learning Center, Liubov Polushkina, 215673
MUTATIONAL PROFILES OF CLASSIC MYELOPROLIFERATIVE NEOPLASMS IN TAIWANESE PATIENTS: FREQUENCY AND CLINICAL CORRELATION
EHA Learning Center, Huan-Chau Lin, 215674
DOMINANT CYTOTOXIC NK CELL SUBSET WITHIN CLPD-NK PATIENTS IDENTIFIES A MORE AGGRESSIVE NK CELL PROLIFERATION
EHA Learning Center, Gregorio Barilà, 215689
IMMUNOPROFILING OF HIV-ASSOCIATED LYMPHADENOPATHY: HIGH-THROUGHPUT ANALYSIS OF THE T CELL RECEPTOR GENE REPERTOIRE SUPPORTS EPITOPE-SPECIFIC T CELL RESPONSES
EHA Learning Center, Evangelia Stalika, 215690
SUPERIORITY OF AVATROMBOPAG TO PLACEBO IN I REDUCING PLATELET TRANSFUSIONS IN PATIENTS WITH THROMBOCYTOPENIA AND CHRONIC LIVER DISEASE UNDERGOING SCHEDULED PROCEDURES- POOLED ANALYSIS OF 2 STUDIES
EHA Learning Center, Kavita Aggarwal, 215691
IMMATURE PLATELET FRACTION AS A MARKER OF THROMBOPOIESIS IN THROMBOCYTOPENIC PATIENTS
EHA Learning Center, David J Camilleri, 215706
CHANGES IN PLATELET AGGREGATION DURING PREGNANCY AND THE IMMEDIATE POSTPARTUM PERIOD
EHA Learning Center, Brwa Hussein, 215707
CHANGING PROFILE OF PLATELET ACTIVITY AND TURNOVER INDICES DURING TREATMENT RESPONSE OF IMMUNE THROMBOCYTOPENIA: PREDICATIVE VALUE OF REPONSE BY GLYCOCALICIN AND SOLUBLE CD40 LIGAND
EHA Learning Center, Hung Chang, 215708
QUALITY OF LIFE IN PATIENTS WITH RARE HEREDITARY HEMOLYTIC ANEMIA, THE IMPORTANCE OF SOCIAL SUPPORT
EHA Learning Center, Stephanie van Straaten, 215723
HOW PHYSICIANS' AND PATIENTS' CHARACTERISTICS AFFECT THE LENGTH OF PATIENTS' VISIT IN THE HEMATO-ONCOLOGICAL CLINIC.
EHA Learning Center, IRINA AMITAI, 215724
COMPLEMENT ACTIVATION IN HOMOZYGOUS SICKLE CELL DISEASE PATIENTS IS MODULATED BY HYDROXYUREA
EHA Learning Center, Lubka Roumenina, 215739
EARLY RECOGNITION OF THE SICKLING PROCESS OF ERYTHROCYTES BY LABEL-FREE LIGHT MICROSCOPIC IMAGING IN PATIENTS WITH SICKLE CELL DISEASE
EHA Learning Center, Irene Lorand Metze, 215741
COMPARISON OF REDUCED-INTENSITY CONDITIONING REGIMENS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA > 45 YEARS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION – A RETROSPECTIVE STUDY BY THE ALWP/EBMT
EHA Learning Center, Zinaida Peric, 215756
A PHASE I/II TRIAL OF INTRAVENOUS AZACITIDINE FOR ACUTE GVHD PROPHYLAXIS IN PATIENTS UNDERGOING MATCHED UNRELATED STEM CELL TRANSPLANTATION: INTERIM PHASE II RESULTS
EHA Learning Center, Mark Schroeder, 215757
UTILIZATION AND OUTCOMES OF FERTILITY PRESERVATION TECHNIQUES IN WOMEN UNDERGOING ALLOGENIC HEMATOPOIETIC CELL TRANSPLANT
EHA Learning Center, Alexandra Higgins, 215772
LOW INCIDENCE OF SYMPTOMATIC OSTEONECROSIS AFTER ALLOGENEIC HSCT IN CHILDREN WITH HIGH-RISK OR RELAPSED ALL – RESULTS OF THE ALL-SCT 2003 TRIAL
EHA Learning Center, Michaela Kuhlen, 215773
AN UNBALANCED MONOCYTE MACROPHAGE POLARIZATION IN THE BONE MARROW MICROENVIRONMENT MAY CAUSE THE OCCURRENCE OF POOR GRAFT FUNCTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Learning Center, Hong-Yan Zhao, 215788
COMPLEMENT-RELATED GENETIC VARIANTS IN ADULT ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS WITH TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY
EHA Learning Center, Eleni Gavriilaki, 215789
CEREBRAL IRON OVERLOAD IN BETA THALASSEMIA: DOES IT REALLY MATTER?
EHA Learning Center, Immacolata Tartaglione, 215805
LEPTIN IS ASSOCIATED WITH THE DEGREE OF ANEMIA AND THE ERYTHROPOIETIN LEVELS IN Β THALASSEMIA PATIENTS
EHA Learning Center, Carina Levin, 215806
PLATELETPHERESIS-ASSOCIATED LYMPHOPENIA IN FREQUENT PLATELET DONORS
EHA Learning Center, John Gansner, 215821
INTRACRANIAL HEMORRHAGE IN LEUKEMIA PATIENTS: PRELIMINARY RESULTS OF AN ONGOING NESTED CASE CONTROL STUDY
EHA Learning Center, Loes Cornelissen, 215822
INTERLEUKIN-15-CULTURED DENDRITIC CELLS ENHANCE ANTI-TUMOR GAMMA DELTA T CELL FUNCTIONS THROUGH IL-15 SECRETION
EHA Learning Center, Heleen Van Acker, 215901
PI3P MODULATES MEGAKARYOCYTE MATURATION AND PROPLATELET PRODUCTION IN VITRO
EHA Learning Center, Ivana Bertović, 215902
A DECREASED PLATELET-TO-LYMPHOCYTE RATIO IS ASSOCIATED WITH A LOW PLATELETCRIT IN PRE-DIABETES
EHA Learning Center, Bongani Nkambule, 215917
THE OXYGENSCAN: CONTINUOUS MEASUREMENT AND QUANTIFICATION OF SICKLING DURING DE- AND REOXYGENATION TO MONITOR DISEASE SEVERITY AND TREATMENT EFFECT IN SICKLE CELL DISEASE.
EHA Learning Center, Minke Rab, 215918

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings